{"id":29043,"date":"2025-03-11T14:39:29","date_gmt":"2025-03-11T06:39:29","guid":{"rendered":"https:\/\/flcube.com\/?p=29043"},"modified":"2025-03-11T14:39:32","modified_gmt":"2025-03-11T06:39:32","slug":"illumina-responds-to-chinese-mofcom-notice-amid-sequencing-instrument-export-ban","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=29043","title":{"rendered":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban"},"content":{"rendered":"\n

US major Illumina (NASDAQ: ILMN<\/a>), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM’s decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.<\/p>\n\n\n\n

Business Adjustments and Future Plans<\/strong>
Despite the challenges posed by the export restrictions, Illumina remains focused on advancing its multiomics portfolio. The company plans to introduce new roadmap technologies spanning genomics, spatial, single cell, and methylation, as well as develop a new multimodal data analysis platform. These initiatives underscore Illumina’s dedication to innovation and expansion in the field of genomic research and applications.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued…<\/p>\n","protected":false},"author":1,"featured_media":29044,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[1639,1685],"class_list":["post-29043","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-illumina","tag-nasdaq-ilmn"],"yoast_head":"\nIllumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=29043\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban\" \/>\n<meta property=\"og:description\" content=\"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=29043\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T06:39:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-11T06:39:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban\",\"datePublished\":\"2025-03-11T06:39:29+00:00\",\"dateModified\":\"2025-03-11T06:39:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043\"},\"wordCount\":150,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/1105-png.avif\",\"keywords\":[\"Illumina\",\"NASDAQ: ILMN\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=29043#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=29043\",\"name\":\"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/1105-png.avif\",\"datePublished\":\"2025-03-11T06:39:29+00:00\",\"dateModified\":\"2025-03-11T06:39:32+00:00\",\"description\":\"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=29043\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/1105-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/1105-png.avif\",\"width\":1080,\"height\":608,\"caption\":\"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=29043#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban - Insight, China's Pharmaceutical Industry","description":"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=29043","og_locale":"en_US","og_type":"article","og_title":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban","og_description":"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.","og_url":"https:\/\/flcube.com\/?p=29043","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-11T06:39:29+00:00","article_modified_time":"2025-03-11T06:39:32+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=29043#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=29043"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban","datePublished":"2025-03-11T06:39:29+00:00","dateModified":"2025-03-11T06:39:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=29043"},"wordCount":150,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=29043#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","keywords":["Illumina","NASDAQ: ILMN"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=29043#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=29043","url":"https:\/\/flcube.com\/?p=29043","name":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=29043#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=29043#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","datePublished":"2025-03-11T06:39:29+00:00","dateModified":"2025-03-11T06:39:32+00:00","description":"US major Illumina (NASDAQ: ILMN), which was included in a list of unreliable entities issued by China\u2019s Ministry of Commerce (MOFCOM) earlier this year, has responded to the notice from MOFCOM on March 4, 2025. The company faces a prohibition on exporting sequencing instruments into China and has stated its respect for MOFCOM's decision, emphasizing its commitment to complying with all applicable laws and regulations in every jurisdiction it operates in.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=29043#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=29043"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=29043#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","width":1080,"height":608,"caption":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=29043#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/1105-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/29043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29043"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/29043\/revisions"}],"predecessor-version":[{"id":29045,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/29043\/revisions\/29045"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/29044"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}